Michael A. Dorato, PhD, DABT, Fellow ATS, FRSB
Vice President Pharmacology and Toxicology at MBX Biosciences, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Fellow, Academy of Toxicological Sciences
The Academy of Toxicological SciencesJul, 2023- Nov, 2024 -
Fellow Royal Society of Biology
Royal Society of BiologyJan, 2023- Nov, 2024 -
Diplomat, American Board of Toxicology
American Board of Toxicology, Inc.Sep, 1980- Nov, 2024
Experience
-
MBX Biosciences, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President Pharmacology and Toxicology
-
Nov 2020 - Present
Strategic scientific guidance in pharmacology and toxicology regarding development programs and collaborations with academic laboratories and CROs Strategic scientific guidance in pharmacology and toxicology regarding development programs and collaborations with academic laboratories and CROs
-
-
-
Inotiv
-
United States
-
Research Services
-
500 - 600 Employee
-
Sr. Vice President, Toxicology and Pharmacology
-
Nov 2019 - Nov 2020
-
-
-
BASi/Seventh Wave
-
BASi Gathersburg
-
Sr. Vice President, Toxicology and Pharmacology
-
May 2019 - Nov 2019
-
-
-
Smithers Avanza
-
Gaithersburg, Maryland
-
Executive Vice President
-
Apr 2014 - May 2019
Apply my >35 years experience in preclinical safety and efficacy evaluations in providing service to our clients in addressing questions in pharmaceutical discovery and development, agrochemical safety assessments, animal welfare, organizational structure and effective relationships in the client/CRO context. Apply my >35 years experience in preclinical safety and efficacy evaluations in providing service to our clients in addressing questions in pharmaceutical discovery and development, agrochemical safety assessments, animal welfare, organizational structure and effective relationships in the client/CRO context.
-
-
-
-
ACT Mentor
-
2014 - 2015
-
-
ACT Mentor
-
2014 - 2015
-
-
-
M Dorato Associates, LLC Efficacy, Safety and Outsourcing Consultants
-
Indianapolis, Indiana Area
-
Principal Consultant
-
Sep 2012 - Apr 2014
Apply 34+ years of experience, as a researcher and global leader of safety and efficacy strategies in the pharmaceutical (30 years), CRO (4 years) industries and academia to address questions of Drug Discovery and Development, Animal Welfare, Organizational Structure and Effective Working Relationships across pharmaceutical and contract research organizations. CV and Publications/presentation available on request mdorato@mdoratoassociates.com Apply 34+ years of experience, as a researcher and global leader of safety and efficacy strategies in the pharmaceutical (30 years), CRO (4 years) industries and academia to address questions of Drug Discovery and Development, Animal Welfare, Organizational Structure and Effective Working Relationships across pharmaceutical and contract research organizations. CV and Publications/presentation available on request mdorato@mdoratoassociates.com
-
-
-
St. John's University College of Pharmacy and Allied Health Professions
-
Jamaica, Queens, N.Y.
-
Visiting Scholar
-
Sep 2011 - Dec 2012
Advised on science and professional activities in the College of Pharmacy, delivered lectures on current issues in Toxicology and Drug Safety, interacted with graduate and undergraduate students, discussed research approaches with faculty including effective relationships between academic researchers and pharmaceutical industry researchers. Advised on science and professional activities in the College of Pharmacy, delivered lectures on current issues in Toxicology and Drug Safety, interacted with graduate and undergraduate students, discussed research approaches with faculty including effective relationships between academic researchers and pharmaceutical industry researchers.
-
-
-
Covance
-
United States
-
Research Services
-
700 & Above Employee
-
Vice President and CSO Global Discovery Services
-
Jul 2008 - Dec 2012
Global Discovery leadership across LO Toxicology, Discovery Pathology, Discovery Operations, In Vivo Pharmacology (Neuroscience, Oncology, Cardiovascular and Metabolic Diseases, Inflammation, Renal and Bone, Receptor Occupancy), Molecular and Anatomical Imaging, Nuclear Medicine in the Discovery and Translational Services Busineness Unit Global Discovery leadership across LO Toxicology, Discovery Pathology, Discovery Operations, In Vivo Pharmacology (Neuroscience, Oncology, Cardiovascular and Metabolic Diseases, Inflammation, Renal and Bone, Receptor Occupancy), Molecular and Anatomical Imaging, Nuclear Medicine in the Discovery and Translational Services Busineness Unit
-
-
-
Eli Lilly and Company
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Executive Director, Toxicology
-
Jan 2005 - Jul 2008
Global leadership of all aspects of Toxicology and Pathology research, discovery and development.
-
-
Various scientific and management leadership positions across toxicology discovery and development
-
Sep 1978 - Jan 2005
Head and Director level roles leading Toxicology Studies, Environmental Toxicology, Inhalation Toxicology, Biochemical Toxicology, Neuroscience and Cardiovascular Research, Nonclinical Safety Assessment and Environmental Sciences
-
-
-
Huntingdon Life Sciences
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Inhalation Toxicologist
-
Jun 1976 - Sep 1978
Responsible for Inhalation Toxicology studies, aerosol particle sizing, environmental chemicals and pharmaceuticals. Organization known as Huntingdon Research Centre at the time. Responsible for Inhalation Toxicology studies, aerosol particle sizing, environmental chemicals and pharmaceuticals. Organization known as Huntingdon Research Centre at the time.
-
-
Education
-
Saint John's University
Ph.D., Pharmacology -
Saint John's University
BS, MS, PhD, Pharmacy, Pharmacology